GSK3B and Alzheimer disease: Although evidence of tau hyperphosphorylation by GSK-3β and ERK strongly indicates an impairment of the IR pathway as a risk factor in AD, the underlying mechanisms that link insulin resistance to tau hyperphosphorylation remain unclear.